Wall Street brokerages predict that Stericycle Inc (NASDAQ:SRCL) will post earnings per share of $0.84 for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Stericycle’s earnings, with the lowest EPS estimate coming in at $0.80 and the highest estimate coming in at $0.88. Stericycle reported earnings of $1.17 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 28.2%. The business is expected to announce its next quarterly earnings report on Thursday, August 1st.

According to Zacks, analysts expect that Stericycle will report full year earnings of $3.35 per share for the current fiscal year, with EPS estimates ranging from $3.19 to $3.53. For the next financial year, analysts expect that the business will report earnings of $3.92 per share, with EPS estimates ranging from $3.62 to $4.81. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that cover Stericycle.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, February 28th. The business services provider reported $1.03 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.96 by $0.07. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. The company had revenue of $852.70 million for the quarter, compared to analyst estimates of $848.75 million.

SRCL has been the subject of a number of research reports. Zacks Investment Research upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, May 1st. ValuEngine upgraded shares of Stericycle from a “strong sell” rating to a “sell” rating in a research report on Tuesday, March 5th. Robert W. Baird downgraded shares of Stericycle from a “neutral” rating to an “underperform” rating and set a $44.00 price target for the company. in a research report on Wednesday, April 17th. BidaskClub upgraded shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Wednesday, February 13th. Finally, Goldman Sachs Group upgraded shares of Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 price target for the company in a research report on Friday, March 1st. Four investment analysts have rated the stock with a sell rating, three have given a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average price target of $59.00.

SRCL stock opened at $48.93 on Tuesday. Stericycle has a 12-month low of $34.36 and a 12-month high of $71.43. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market cap of $4.44 billion, a PE ratio of 11.00, a P/E/G ratio of 1.90 and a beta of 1.11.

In other news, Director Mark C. Miller sold 260,314 shares of Stericycle stock in a transaction that occurred on Tuesday, April 9th. The shares were sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the completion of the sale, the director now directly owns 325,848 shares in the company, valued at approximately $18,631,988.64. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 2.30% of the stock is currently owned by company insiders.

Institutional investors have recently modified their holdings of the stock. Bank of New York Mellon Corp raised its holdings in Stericycle by 2.5% in the 3rd quarter. Bank of New York Mellon Corp now owns 634,107 shares of the business services provider’s stock valued at $37,209,000 after acquiring an additional 15,590 shares during the last quarter. AQR Capital Management LLC acquired a new position in Stericycle in the 3rd quarter valued at $281,000. Neuberger Berman Group LLC raised its holdings in Stericycle by 42.0% in the 3rd quarter. Neuberger Berman Group LLC now owns 837,494 shares of the business services provider’s stock valued at $49,143,000 after acquiring an additional 247,502 shares during the last quarter. Standard Life Aberdeen plc raised its holdings in Stericycle by 555.1% in the 3rd quarter. Standard Life Aberdeen plc now owns 132,015 shares of the business services provider’s stock valued at $7,746,000 after acquiring an additional 111,864 shares during the last quarter. Finally, Morgan Stanley raised its holdings in Stericycle by 117.0% in the 3rd quarter. Morgan Stanley now owns 586,130 shares of the business services provider’s stock valued at $34,393,000 after acquiring an additional 316,081 shares during the last quarter. Hedge funds and other institutional investors own 96.52% of the company’s stock.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.

Recommended Story: How is the discount rate different from the Federal Funds rate?

Get a free copy of the Zacks research report on Stericycle (SRCL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.